Related Experiment Video
Updated: Aug 18, 2025
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Advancements in melanoma cancer metastasis models
Luiza Martins Nascentes Melo1, Suresh Kumar1, Valeria Riess1
1Department of Dermatology, University Hospital Essen and German Cancer Consortium, Essen, Germany.
Abstract:
Metastatic melanoma is a complex and deadly disease. Due to its complexity, the development of novel therapeutic strategies to inhibit metastatic melanoma remains an outstanding challenge. Our ability to study metastasis is advanced with the development of in vitro and in vivo models that better mimic the different steps of the metastatic cascade beginning from primary tumor initiation to final metastatic seeding. In this review, we provide a comprehensive summary of in vitro models, in vivo models, and in silico platforms to study the individual steps of melanoma metastasis. Furthermore, we highlight the advantages and limitations of each model and discuss the challenges of how to improve current models to enhance translation for melanoma cancer patients and future therapies.
Insights
Developing new treatments for metastatic melanoma is difficult. This review summarizes models for studying melanoma metastasis, aiding the development of future therapies for patients.
Area of Science:
- Oncology
- Cancer Research
- Melanoma Metastasis
Background:
- Metastatic melanoma is a complex and lethal cancer.
- Developing novel therapeutic strategies for metastatic melanoma is challenging.
- Studying melanoma metastasis requires accurate models of the metastatic cascade.
Purpose of the Study:
- To provide a comprehensive summary of current models for studying melanoma metastasis.
- To highlight the advantages and limitations of various in vitro, in vivo, and in silico platforms.
- To discuss challenges and potential improvements in models for enhanced clinical translation.
Main Methods:
- Review of existing literature on in vitro, in vivo, and in silico models.
- Analysis of the strengths and weaknesses of each model type.
- Discussion of the translational potential of current models.
Main Results:
- Various in vitro, in vivo, and in silico models exist to study melanoma metastasis.
- Each model type offers unique advantages and possesses inherent limitations.
- Current models require improvement to better reflect the complexity of melanoma metastasis in patients.
Conclusions:
- Accurate models are crucial for understanding and combating melanoma metastasis.
- Addressing the limitations of current models is essential for advancing therapeutic development.
- Improved models will enhance the translation of research findings to clinical applications for melanoma patients.
